Other Liabilities - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Corcept Therapeutics Inc
Other Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Other Liabilities
$17.6m
CAGR 3-Years
253%
CAGR 5-Years
145%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Other Liabilities
$21.3B
CAGR 3-Years
-10%
CAGR 5-Years
-5%
CAGR 10-Years
4%
Bristol-Myers Squibb Co
NYSE:BMY
Other Liabilities
$5B
CAGR 3-Years
-13%
CAGR 5-Years
1%
CAGR 10-Years
6%
Pfizer Inc
NYSE:PFE
Other Liabilities
$24.7B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Other Liabilities
$7.3B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Eli Lilly and Co
NYSE:LLY
Other Liabilities
$7.4B
CAGR 3-Years
-8%
CAGR 5-Years
-1%
CAGR 10-Years
6%

See Also

What is Corcept Therapeutics Inc's Other Liabilities?
Other Liabilities
17.6m USD

Based on the financial report for Jun 30, 2024, Corcept Therapeutics Inc's Other Liabilities amounts to 17.6m USD.

What is Corcept Therapeutics Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
145%

Over the last year, the Other Liabilities growth was 76%. The average annual Other Liabilities growth rates for Corcept Therapeutics Inc have been 253% over the past three years , 145% over the past five years .

Back to Top